Caplight Directory>Investors>Essex Bio-Technology>Essexbio


Essex Bio-Technology

Essex Bio-Technology

Hong Kong SARessexbio.com

Overview

Essex Bio-Technology is a bio-pharmaceutical company that develops, manufactures, and commercializes genetically engineered therapeutic rb-bFGF (FGF-2). Its products are principally prescribed for wound healing and diseases in Ophthalmology and Dermatology. The company is publicly listed on the Hong Kong Stock Exchange and, through a subsidiary named Essex Bio-Investment, also makes strategic investments in other companies. The company's products are sold in approximately 14,100 hospitals in China.

Portfolio Companies

3

Investments

CompanyDateStageLead
X-ZELLOct 2020SeedCo-investor
KroniKareOct 2020Series ACo-investor
MitotechJul 2018StrategicLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersHong Kong SAR
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.